Biomarkers Market Analysis by Disease Type (Cardiovascular Diseases, Cancer, Neurological Diseases, Immunological Diseases), by Type (Safety, Efficacy, Validation Biomarkers), by Application & by Region - Global Forecast 2022-2032

ROCKVILLE, Md., March 14, 2022 (GLOBE NEWSWIRE) -- The biomarkers market revenues were estimated at US$ 59.1 Bn in 2021 and is anticipated to grow at a CAGR of 15.3% from 2022-2032, according to a recently published Fact.MR report. By the end of 2032, the market is expected to reach US$ 278 Bn.

Safety Biomarkers held a market share of nearly 38% and this trend is likely to be continued due to the predicted CAGR of 15.9% in the next ten years. Market growth is expected to be fueled by the growing demand for Safety Biomarkers owing to its demand being driven by high awareness of regular health checks, low usage of medicines, and an increasing population at high risk of developing various diseases such as cancer, cardiovascular and kidney ailments.

Get an Idea about the Offerings of Our Biomarkers Market Report from this Brochure at
https://www.factmr.com/connectus/sample?flag=S&rep_id=7181

Biomarkers Market Report Scope

Attribute	Details
Forecast Period	2022-2032
Historical Data Available for	2017-2021
Market Analysis	US$ Bn for Value
Key Regions Covered	• North America • Latin America • Europe • East Asia • South Asia • Oceania • MEA
Key Market Segments Covered	• Disease • Application • Region
Key Companies Profiled	• F. Hoffmann-La Roche Ltd. • Abbott Laboratories • Epigenetics AG • General Electric • Johnson & Johnson Services, Inc. • Thermo Fisher Scientific, Inc. • Bio-Rad Laboratories, Inc. • Siemens Healthineers AG • Qiagen

Key Takeaways from the Market Study

• Global biomarkers market is expected to reach a market size of US$ 278 Bn by 2032.
• In 2022, North America to contribute more than 30% market revenue.
• Safety Biomarkers demand accounted for 38% of the market revenue in 2022
• Cancer detection show the highest potential for growth in the disease type segment. It is expected to grow at a rate of about 17.1% from 2022- 2032.
• U.S., the key market is expected to hold the prominent market share and grow at a CAGR of 16.7% during 2022 - 2032.
  
  

To learn more about Biomarkers market, you can get in touch with our Analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=7181
Competitive Landscape
A number of regional and global players operate in this market. These companies compete based on the innovation of their products, their quality, their brand reputation, and their market presence in order to sell their products through various industries. A variety of strategies are being employed by companies to remain competitive.

• In May 2021, the Cerascreen KRAS RGQ PCR kit, the first FDA-approved diagnostic tissue sample to identify KRAS G12C mutations in QIAGEN NV NSCLC tumors and expand precision medical options for lung cancer, was launched.
• In April 2021, F. Hoffmann La Roche Ltd. Introduced two cardiac biomarker tests, the sensitive cardiac troponin T (cTnThs) and the N-terminal pro-brain natriuretic peptide test (NTproBNP). These gold standard biomarkers support the management of cardiovascular disease and may help physicians diagnose heart attacks and better manage heart failure.
• In July 2020, Thermo Fisher Scientific signed a contract with to expand the use of the targeted Oncomin-Dx test in patients with non-small cell lung cancer (NSCLC) and accelerate local biomarker testing.
• In January 2020, Merck KGaA opened a non-profit high-tech capacity development center in Chandigarh, India, in collaboration with the Institute for Microbial Technology (CSIRIMTECH) of the Scientific and Industrial Research Council. The center is has single-molecule biomarker detection, genome editing, and other technologies to help onsite students gain life science skills.

The impact of COVID-19 on Biomarkers was not much seen in biomarkers market. Despite the heavy blows to almost all the industries, the Biomarkers industry generated a revenue of US$ 59 Bn in 2021 and continued to grow positively at a rate of 14% over the last year. The reason for the growth of the industry during the pandemic may be credited to the growing health concern of the customers during the pandemic.
Get Customization on this Biomarkers Market Report for Specific Research Solutions at
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7181

Market Segments Covered in Biomarkers Industry Analysis

• By Disease Type :
  • Cardiovascular Diseases
  • Cancer
  • Neurological Diseases
  • Immunological Diseases
  • Other Disease Types
• By Type :
  • Safety
  • Efficacy
  • Validation
• By Application :
  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicines
  • Other Applications
    

Revenue of Biomarkers from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

The constant surge in urbanization is propelling the demand for various commodities which is consequently driving the need for logistics. Owing to this, Biomarkers market is projected to grow at a CAGR of 15.3% over the coming 10 years.

• The Biomarkers market reached a valuation of US$ 59.1 Bn in 2021. Fact.MR estimates that Biomarkers revenue will grow 4.1X from 2022 to 2032, reaching nearly US$ 278 Bn in 2032.
• Safety Biomarkers are held the largest share in the market of 38%.
• Japan is expected to be the fastest growing market for Biomarkers, with a CAGR of 17.2%.
• Cancer detection show the highest potential for growth in the Biomarkers industry in the disease type segment. It is expected to grow at a rate of about 17.1% during the next ten years.

To understand how our report can bring difference to your business strategy, Purchase a copy of this report at https://www.factmr.com/checkout/7181

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the biomarkers market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Type (Safety, Efficacy, Validation), by Disease Type (Cardiovascular Diseases, Cancer, Neurological Diseases, Immunological Diseases, Other Disease Types), by Application (Diagnostics, Drug Discovery & Development, Personalized Medicines, Other Applications) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

About the Healthcare Division at Fact.MR

Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare team at Fact.MR helps clients from across the globe with their unique business intelligence needs. With a repertoire of over thousand reports and 1 million-plus data points, the team has analyzed the chemicals industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

For more information, refer to our market research report or contact the PR author.

Check out more studies related to Healthcare Industry, conducted by Fact.MR:

Revenue of Basin, Bowl and Cup Market Outlook for 2022 to 2032 - As per the Basin, Bowl and Cup industry research by Fact.MR - a market research and competitive intelligence provider, historically, from 2017 to 2021, market value of the Basin, Bowl and Cup industry increased at around 15.8% CAGR, wherein, countries such as the U.S., China, UK, South Korea and Japan held significant share in the global market.

Clinical Dermatology CRO Remains the Faster Revenue Generating Segment - Clinical dermatology CRO is the fastest revenue generating segment because it offers a wide range of services that can be customized to meet the specific needs of each client. This allows for quick turnaround times and efficient project management, which results in increased profits for the client.

Growth of Clear Aligners Industry - Clear aligners are customized for a particular treatment level for a particular patient. The solution providers have mass customization capabilities such as world-class clear aligner design staff, comprehensive digital fitting design system, sufficient number of 3D printers and other equipment to manufacture clear aligners.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com   
Tel: +1 (628) 251-1583

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.